Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating a subject having an EGFR-positive and/or ErbB-3-positive tumor

Methods of treating a subject having an EGFR-positive and/or ErbB-3-positive tumor

US Patent 11820825 · Granted Nov 21, 2023

Estimated economic value: $17,366,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies that bind PSMA and gamma-delta T cell receptors2025
Bispecific antibody2025
Bispecific antibody2025
Generation of binding molecules2025
Generation of binding molecules2025
ERBB-2 and ERBB-3 binding bispecific antibodies for use in the treatment of cell2025
ERBB-2 and ERBB-3 binding bispecific antibodies for use in the treatment of cell2025
Antibody that binds ErbB-2 and ErbB-32024
Antibody that binds ErbB-2 and ErbB-32024
Methods and means for the production of Ig-like molecules2024
Bispecific antibody2024
Bispecific IgG antibodies as T cell engagers2024